Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Iatrogenic choroidal neovascularization.

J I Lim1

  • 1The Doheny Eye Institute, Los Angeles, California 90033, USA.

Survey of Ophthalmology
|December 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment.

Eye (London, England)·2015
Same author

Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab.

Eye (London, England)·2013
Same author

Compressive mechanical properties of bovine cortical bone under varied loading rates.

Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2011
Same author

Primary transpupillary thermotherapy for small choroidal melanomas.

The British journal of ophthalmology·2007
Same author

Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.

The British journal of ophthalmology·2007
Same author

An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats.

The Journal of pharmacology and experimental therapeutics·2006
Same journal

Macular telangiectasia masqueraders.

Survey of ophthalmology·2026
Same journal

Utilization of anterior segment optical coherence tomography in childhood glaucoma: A systematic review.

Survey of ophthalmology·2026
Same journal

Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies.

Survey of ophthalmology·2026
Same journal

Prognostic factors and postoperative outcomes in pediatric cataract patients: A systematic review and meta-analysis.

Survey of ophthalmology·2026
Same journal

Predicting the progression of proliferative diabetic retinopathy: Pathophysiology, imaging phenotypes, and determinants of disease persistence despite therapy.

Survey of ophthalmology·2026
Same journal

Comment on "Quantitative imaging for assessing uveitis activity: A comprehensive review".

Survey of ophthalmology·2026
See all related articles

Iatrogenic choroidal neovascularization, a complication of eye surgery, arises from tissue damage and angiogenic factors. Prevention involves minimizing laser energy, avoiding re-treatment, and reducing surgical trauma.

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Surgical Complications

Background:

  • Iatrogenic choroidal neovascularization (iCNV) is a rare complication following ocular procedures like laser photocoagulation.
  • Damage to Bruch's membrane and retinal pigment epithelium (RPE) initiates reparative processes releasing angiogenic factors, contributing to iCNV.
  • Inflammatory cells and choroidal ischemia are potential contributing factors to iCNV development.

Purpose of the Study:

  • To summarize the causes and risk factors of iatrogenic choroidal neovascularization.
  • To discuss the prognostic variability based on iCNV type and underlying conditions.
  • To outline preventive strategies for iatrogenic choroidal neovascularization.

Main Methods:

  • Review of existing literature on iatrogenic choroidal neovascularization.

Related Experiment Videos

  • Analysis of factors contributing to iCNV.
  • Synthesis of information on prognosis and prevention.

    • Main Results:

    • iCNV results from damaged Bruch's membrane/RPE, triggering angiogenic factor release.
    • Prognosis of iCNV is variable, depending on the specific type (subretinal, chorioretinal, choriovitreal) and associated diseases.
    • Preventive measures include limiting laser energy, avoiding repeat treatments, and minimizing mechanical trauma to ocular tissues.

    Conclusions:

    • Understanding the pathophysiology of iCNV is crucial for risk mitigation.
    • Careful surgical technique and judicious use of laser energy can reduce the incidence of iCNV.
    • Further research may elucidate more targeted preventive strategies for iatrogenic choroidal neovascularization.